The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline NQO1c.559C>T as a biomarker of genetic susceptibility to immune checkpoint blockade resistance.
 
Jose Carlos Benitez
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; AstraZeneca Spain; Daiichi Sankyo/Astra Zeneca; Roche; Sanofi; Takeda
 
Javier Oliver
No Relationships to Disclose
 
Juan Luis Onieva
No Relationships to Disclose
 
Manuel Cobo
Consulting or Advisory Role - Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Lilly, MSD, Takeda, Phyzer, Kyowa, Sanofi,Jansen
Speakers' Bureau - Novartis, AstraZeneca, Boehringer-Ingelheim, Roche, BMS, Lilly, MSD, Takeda, Kyowa, Pierre-fabre, Novocure, Sanofi, Jansen
 
Andres Mesas
No Relationships to Disclose
 
Alberto Rios-Muñoz
No Relationships to Disclose
 
Elisabeth Perez Ruiz
No Relationships to Disclose
 
Maria Garrido-Barros
No Relationships to Disclose
 
Paula Vazquez Rojas
No Relationships to Disclose
 
Beatriz Martinez
No Relationships to Disclose
 
Alexandra Cantero-Gonzalez
No Relationships to Disclose
 
Andrea Gonzalez
No Relationships to Disclose
 
Juan Zafra Martín
No Relationships to Disclose
 
Isabel Barragán
No Relationships to Disclose
 
Antonio Rueda Dominguez
No Relationships to Disclose